Medical Economics November 26, 2024
Will it take effect? Biden proposal would be finalized in Trump’s term, and his pick to lead HHS has spoken against antiobesity drugs.
Medicare Part D and Medicaid would expand drug coverage to include new antiobesity medications, according to a proposal by the administration of President Joe Biden.
The U.S. Centers for Medicare & Medicaid Services (CMS) announced the proposal for the contract year 2026 proposed rule for Medicare Advantage and Medicare Part D. The rule aims to hold the plans “more accountable for delivering high-quality coverage so that people with Medicare are connected to the care they need when they need it,” the announcement said.
Allowing the coverage would change a policy in place more than 20 years. The...
Today's Sponsors
Today's Sponsor